m+Medelevator.RU
← Поиск публикаций
Frontiers in neurology · 2025

Continuous visual stimulus tracking to quantify eye motility in spinocerebellar ataxia type 3.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

de Boer M J, Wasmann R A, Pott J W R, Cornelissen F W, Jansonius N M

Аннотация

INTRODUCTION: Spinocerebellar ataxias (SCA) form a group of dominantly inherited neurodegenerative diseases represented by progressive cerebellar ataxia and various other neurological deficits. SCA3 is the most prevalent type globally and represents 28% of the autosomal dominant cerebellar ataxias in The Netherlands. The associated oculomotor disorders, with distance esotropia as its hallmark, cause diplopia and often present early. To gain further insight into this, we examined eye movements made during a continuous visual stimulus tracking task (SONDA; Standardized Oculomotor and Neuro-Ophthalmic Disorder Assessment).

METHODS: Thirteen genetically confirmed SCA3 cases underwent SONDA, both monocularly and binocularly. As a reference, we used previously collected data from 36 monocularly and 13 binocularly measured healthy subjects.

RESULTS: SCA3 cases were well capable of tracking the moving stimulus, but they performed the task differently. More specifically, their eyes were not synchronized in their movements, and they made multiple small saccades in response to a large stimulus jump instead of a larger saccade followed by a small corrective saccade. The saccadic amplitude distribution shape was related to the severity of the oculomotor disorder, suggesting that the saccadic amplitude distribution could be used as a biomarker of disease severity.

CONCLUSION: Overall, this study highlights that eye-tracking during a standardized task can give valuable insights into how eye movements are affected in SCA3 and provides suggestions for potential biomarkers for severity and the associated treatment options. Longitudinal research is needed to elaborate on these findings and validate the proposed biomarkers.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты